IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,000 | -25.0% | 203 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $3,000 | +50.0% | 203 | +22.3% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -66.7% | 166 | -33.3% | 0.00% | -66.7% |
| Q3 2016 | $6,000 | 0.0% | 249 | +20.9% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | +20.0% | 206 | +19.8% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 172 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $7,000 | +16.7% | 172 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -25.0% | 172 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $8,000 | 0.0% | 172 | -3.9% | 0.01% | 0.0% |
| Q1 2015 | $8,000 | +60.0% | 179 | +4.1% | 0.01% | +66.7% |
| Q4 2014 | $5,000 | 0.0% | 172 | -15.3% | 0.00% | -25.0% |
| Q3 2014 | $5,000 | 0.0% | 203 | +11.5% | 0.00% | +33.3% |
| Q2 2014 | $5,000 | 0.0% | 182 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $5,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |